Evotec, Plectonic Biotech Partner on Research of Novel Immunotherapy for Solid Tumors

MT Newswires · 2d ago
03:14 AM EDT, 09/02/2026 (MT Newswires) -- Evotec (EVT.F) said Wednesday it is collaborating with Plectonic Biotech to research a novel immunotherapy for solid tumors. The German life science company's proprietary BiTco platform will be combined with Plectonic's Logibody technology as part of the partnership.